Study proposes reconsidering how histone deacetylase inhibitors work in cancer treatment
The authors propose that HDAC inhibitors may also interfere with other proteins and that targeting such proteins may suppress cancer.
Read More
Stay in the know about the scientific research conducted at Baylor College of Medicine with From the Labs, the spotlight for the newest and most interesting research findings from the bench at the College.
The authors propose that HDAC inhibitors may also interfere with other proteins and that targeting such proteins may suppress cancer.
Read MoreThis laboratory platform is a powerful way to study Alzheimer’s disease and other tau-caused conditions.
Read MoreThe CPRIT awards will support innovative cancer research, treatments and training programs.
Read MoreWith MARRVEL-MCP researchers can analyze and interpret vast amounts of biological information on rare genetic diseases using everyday language.
Read MoreThe findings open the possibility of public health interventions in the future.
Read MoreThe findings support conducting human studies to assess the safety and efficacy of this treatment that could potentially benefit millions of people with dry eye disease.
Read MoreThe Michael E. DeBakey M.D. Award for Excellence in Research recognizes outstanding published scientific contributions over a three-year period.
Read MoreEstes is a leader in virology whose work has shaped the understanding of viruses that cause gastrointestinal disease.
Read MoreDamaged endothelial cells in blood vessels are not passive bystanders, their response can potentially slow down atherosclerosis progression.
Read MoreThe findings suggest that disrupting the cellular makeup of pro-metastatic niches could help treat metastases across multiple cancer types, in both women and men.
Read More